Tramadol can cause seizures because it does more than just relieve pain. Unlike most opioid painkillers, tramadol also blocks the reabsorption of serotonin and norepinephrine in the brain, two chemical messengers that regulate mood, alertness, and nerve signaling. When serotonin levels climb too high, neurons can fire uncontrollably, and that excessive electrical activity is what triggers a seizure. This risk exists at normal prescribed doses, though it rises sharply at higher doses and when tramadol is combined with certain other medications.
How Tramadol Differs From Other Painkillers
Most opioid painkillers work almost exclusively on opioid receptors, the brain’s natural pain-dampening system. Tramadol does that too, but it has a second mechanism that sets it apart: it acts like an antidepressant. The drug is a 1:1 mixture of two mirror-image molecules. One primarily blocks serotonin reuptake while the other blocks norepinephrine reuptake. This dual action is what gives tramadol its unusual side-effect profile, including both serotonin syndrome and seizures.
That antidepressant-like quality is the core of the problem. Serotonin plays a role in regulating electrical excitability throughout the brain. In small, controlled amounts, boosting serotonin is therapeutic. But when levels spike too high or too fast, the brain’s normal inhibitory controls can be overwhelmed, and neurons begin firing in a synchronized, runaway pattern. That’s a seizure.
The Brain Chemistry Behind Tramadol Seizures
Two overlapping mechanisms lower the seizure threshold when you take tramadol.
The first is excessive serotonin activity. Seizures from tramadol share risk factors with serotonin syndrome, a condition where dangerously high serotonin levels cause muscle rigidity, fever, and agitation. Both conditions stem from the same root cause: too much serotonergic stimulation in the central nervous system. The difference is largely one of degree and which brain circuits are most affected.
The second involves the brain’s main “braking system,” a neurotransmitter called GABA. GABA normally calms nerve activity and prevents neurons from becoming overexcited. Animal research has shown that tramadol can suppress GABA’s calming effect through an opioid-dependent pathway, essentially releasing the brake on neural firing. With serotonin pushing excitability up and GABA’s restraining influence weakened, the conditions for a seizure are created from both directions at once.
Parent Drug vs. Metabolites
Your liver breaks tramadol down into several metabolites, the most well-known being O-desmethyltramadol (called M1), which is actually a stronger painkiller than tramadol itself. Researchers have tested whether it’s tramadol or these breakdown products that carry the seizure risk. In mouse studies comparing tramadol, its mirror-image forms, and five of its metabolites, the parent drug tramadol was more potent at inducing seizures than any of its metabolites. The metabolites M1 through M5 were all less potent. This means the seizure risk comes primarily from tramadol itself, not from what your body converts it into.
Dose Matters Significantly
A large nested case-control study of U.S. patients with employer-sponsored health insurance compared seizure risk between tramadol and codeine, another common opioid. At standard doses, the overall seizure risk was similar between the two drugs. But when researchers used a more specific definition of seizure events, tramadol carried a 41% higher risk than codeine alone.
The dose-response relationship was striking. Patients taking 400 mg or more of tramadol daily had roughly double the seizure risk compared to patients on low-dose codeine. That 400 mg threshold is notable because it matches the commonly listed maximum daily dose for tramadol, meaning some people prescribed the upper end of the therapeutic range are already in a higher-risk category.
Drug Combinations That Multiply the Risk
The most dangerous scenario isn’t tramadol alone. It’s tramadol combined with other medications that also raise serotonin levels or lower the seizure threshold. Three classes of drugs are particularly concerning:
- SSRIs (commonly prescribed antidepressants like sertraline or fluoxetine), which also block serotonin reabsorption
- Tricyclic antidepressants (older antidepressants like amitriptyline), which affect both serotonin and norepinephrine
- Antipsychotic medications, which independently lower the seizure threshold
In reported cases, patients who experienced seizures on tramadol were frequently taking one or more of these drugs at the same time. The combination creates a compounding effect: multiple drugs all pushing serotonin higher or removing the brain’s seizure protections simultaneously.
The data on combining tramadol with other opioids is equally concerning. Patients who took both tramadol and codeine had more than double the seizure risk compared to codeine alone in the primary analysis. Under stricter seizure definitions, that risk jumped to nearly six times higher. The takeaway is that mixing tramadol with other opioids doesn’t just add risk, it multiplies it.
Who Faces Higher Risk
Several factors can make someone more susceptible to tramadol-related seizures. A personal or family history of seizures or epilepsy is the most obvious, since the seizure threshold is already lower to begin with. Taking higher doses, whether prescribed or through misuse, increases risk in a dose-dependent way. People who metabolize tramadol unusually quickly (a trait determined by genetics) may experience sharper spikes in the drug’s brain concentration.
Perhaps the most practically important risk factor is polypharmacy, simply taking multiple medications that each nudge serotonin levels upward or lower seizure protection. Because tramadol is often perceived as a “milder” painkiller, it may be prescribed alongside antidepressants without full consideration of how the drugs interact. If you take any medication for depression, anxiety, or a psychiatric condition and are prescribed tramadol, that combination deserves a specific conversation about seizure risk.